Madrigal Pharmaceuticals, Inc.

NASDAQ (USD): Madrigal Pharmaceuticals, Inc. (MDGL)

Last Price

340.14

Today's Change

+15.43 (4.75%)

Day's Change

313.72 - 346.04

Trading Volume

458,381

Overview

Market Cap

7 Billion

Shares Outstanding

21 Million

Avg Volume

474,088

Avg Price (50 Days)

315.26

Avg Price (200 Days)

261.92

PE Ratio

-13.58

EPS

-25.04

Earnings Announcement

26-Feb-2025

Previous Close

324.71

Open

324.75

Day's Range

313.72 - 346.04

Year Range

168.25 - 368.29

Trading Volume

458,381

Price Change Highlight

1 Day Change

4.75%

5 Day Change

24.32%

1 Month Change

9.42%

3 Month Change

67.99%

6 Month Change

21.68%

Ytd Change

8.40%

1 Year Change

48.53%

3 Year Change

439.90%

5 Year Change

316.43%

10 Year Change

293.45%

Max Change

6.91%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment